Mets' Soto leaves with sore left calf, set for MRI...

TourNews newsroom brief · 27m ago · 1 min read · via espn.com

Mets star Juan Soto is scheduled to undergo an MRI on his left calf Saturday after he was removed from Friday's 4-2 loss to the Los Angeles Dodgers in the sixth inning with soreness.

The news of Juan Soto's injury is a significant concern for Mets fans and the team as a whole, as Soto is a key player and a major factor in the team's success. The fact that he is set to undergo an MRI on his left calf suggests that the injury may be more serious than initially thought, and the team is taking a cautious approach to ensure that Soto receives proper treatment and care. This is a crucial time for the Mets, and Soto's absence could have a significant impact on their performance and standings.

The injury to Soto also highlights the importance of player health and safety in professional sports, particularly in baseball where injuries can have a major impact on a team's chances of winning. The Mets will be closely monitoring Soto's condition and will likely take a cautious approach to his recovery, which could mean that he misses several games or even weeks. This is a significant blow to the team, and fans will be eagerly awaiting updates on Soto's condition and when he can expect to return to the field.

As the Mets move forward without Soto, fans will be watching to see how the team responds and who will step up to fill the void left by his absence. The team's upcoming games against the Dodgers and other tough opponents will be a major test, and the Mets will need to find a way to win without one of their star players. Fans will be keeping a close eye on the team's performance and waiting for updates on Soto's condition, and the next few games will be crucial in determining the team's chances of success in the short term.

Originally reported by espn.com. TourNews adds analysis for sports & fitness readers.

Originally reported by espn.com. TourNews curates and briefs the sports & fitness stories that matter. Our editorial policy →
Get the daily tour signal:

More from TourNews

Across the eCorp newsroom network

Part of the eCorp network